Preexisting BCG-Specific T Cells Improve Intravesical Immunotherapy for Bladder Cancer-Reference-Cited by-同舟云学术

Preexisting BCG-Specific T Cells Improve Intravesical Immunotherapy for Bladder Cancer

Published:2012-06-06 Issue:137 Volume:4 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Biot Claire¹²³,Rentsch Cyrill A.¹²⁴,Gsponer Joel R.¹²⁴,Birkhäuser Frédéric D.⁵,Jusforgues-Saklani Hélène¹²,Lemaître Fabrice⁶⁷,Auriau Charlotte¹²,Bachmann Alexander⁵,Bousso Philippe⁶⁷,Demangel Caroline⁸,Peduto Lucie⁹,Thalmann George N.⁵,Albert Matthew L.¹²¹⁰

Affiliation:

1. Unité d’Immunobiologie des Cellules Dendritiques, Department of Immunology, Institut Pasteur, F-75724 Paris, France.

2. INSERM U818, F-75654 Paris, France.

3. MINES ParisTech, F-75272 Paris, France.

4. Department of Urology, University Hospital of Basel, CH-4031 Basel, Switzerland.

5. Department of Urology, University of Bern, Inselspital, CH-3010 Bern, Switzerland.

6. Unité des Dynamiques des Réponses Immunes, Department of Immunology, Institut Pasteur, F-75724 Paris, France.

7. INSERM U668, F-75654 Paris, France.

8. Institut Pasteur, Unité d’Immunobiologie de l’Infection, Department of Immunology, F-75015 Paris, France.

9. Unité de Développement des Tissus Lymphoïdes, Department of Immunology, Institut Pasteur, F-75724 Paris, France.

10. Université Paris Descartes, F-75270 Paris, France.

Abstract

Preexisting immunity to BCG improves treatment response to intravesical BCG therapy for bladder cancer in mouse models and humans.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference51 articles.

1. Global cancer statistics

2. EAU Guidelines on Non–Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 Update

3. Intracavitary Bacillus Calmette-guerin in the Treatment of Superficial Bladder Tumors

4. The Role of Bacillus Calmette-Guérin in the Treatment of Non–Muscle-Invasive Bladder Cancer

5. The BCG World Atlas: A Database of Global BCG Vaccination Policies and Practices

Cited by 220 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging molecular therapies in the treatment of bladder cancer;Exploration of Targeted Anti-tumor Therapy;2024-08-29

2. Update on the Mechanism of Action of Intravesical BCG Therapy to Treat Non-Muscle-Invasive Bladder Cancer;Frontiers in Bioscience-Landmark;2024-08-21

3. Revitalizing Bacillus Calmette–Guérin Immunotherapy for Bladder Cancer: Nanotechnology and Bioengineering Approaches;Pharmaceutics;2024-08-15

4. Mathematical Modeling of Tumor Immune Interactions: The Role of Anti-FGFR and Anti-PD-1 in the Combination Therapy;Bulletin of Mathematical Biology;2024-08-07

5. The impact of purified protein derivative prior to intravesical bacillus Calmette-Guérin for the treatment of patients with non-muscle invasive bladder cancer;Minerva Urology and Nephrology;2024-07